Previous 10 | Next 10 |
THE WOODLANDS, Texas, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results and provided a business update for the three months ended September 30, 2019. “We continue to make good progress on our XERMELO business, with...
THE WOODLANDS, Texas, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will release its third quarter 2019 financial results on Thursday, November 7, 2019 before market opens. Management will conduct a conference call and live webcast at 8:00 a.m. EST (7:0...
SAN DIEGO, CA / ACCESSWIRE / October 29, 2019 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) shares. Investors, who purchased shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) in March 2016 or ...
THE WOODLANDS, Texas, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that data from five posters highlighting XERMELO ® (telotristat ethyl) will be presented at the upcoming North American Neuroendocrine Tumor Society Annual Multi...
Gainers: Dova Pharmaceuticals (NASDAQ: DOVA ) +38% . USA Technologies ( OTC:USAT ) +28% . Farmmi (NASDAQ: FAMI ) +24% . Thor Industries (NYSE: THO ) +21% . GTT Communications (NYSE: GTT ) +15% . Patrick Industries (NASDAQ: PATK ) +12% . Seattle Genetics (NASDAQ: SGEN ) +10% . ...
Lexicon Pharmaceuticals (NASDAQ: LXRX ) is now off 13.8% today on heavy volume following a very bearish take from Seeking Alpha contributor Mako Research. More news on: Lexicon Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...
The Sanofi termination is a disaster for LXRX shareholders and the cash burn will increase dramatically On July 25 th , Lexicon Pharmaceuticals ( LXRX ) received notice from Sanofi ( SNY ) ‘purporting’ to terminate their key alliance around the SGLT2 inhibitor sotagliflozin...
"Men in rage strike those that wish them best. ”― William Shakespeare, Othello The market broke its three-week winning streak last week. The Dow was off approximately one percent while the Russell 2000 declined just slightly more on a percentage basis. Both the S&P 500 a...
InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...
News, Short Squeeze, Breakout and More Instantly...
Lexicon Pharmaceuticals Inc. Company Name:
LXRX Stock Symbol:
NASDAQ Market:
Lexicon Pharmaceuticals Inc. Website:
THE WOODLANDS, Texas, May 14, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced a new post-hoc analysis of clinical data showing that INPEFA ® (sotagliflozin), a dual oral inhibitor of SGLT2 and SGLT1, reduced the risk of heart failure-related ...
THE WOODLANDS, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced its participation in the Bank...
THE WOODLANDS, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the Bank of America Securities Healthcare Conference 2024. Jeff Wade, Lexicon’s president and chief financial officer, will make a company presentati...